Nutrition and Nutrigenomics Group, Research and Innovation Centre, FEM-IASMA, 38010, S. Michele a.A, Trento, Italy,
Genes Nutr. 2011 Aug;6(3):241-60. doi: 10.1007/s12263-011-0230-1. Epub 2011 May 11.
Obesity is now considered a major public health concern globally as it predisposes to a number of chronic human diseases. Most developed countries have experienced a dramatic and significant rise in obesity since the 1980s, with obesity apparently accompanying, hand in hand, the adoption of "Western"-style diets and low-energy expenditure lifestyles around the world. Recent studies report an aberrant gut microbiota in obese subjects and that gut microbial metabolic activities, especially carbohydrate fermentation and bile acid metabolism, can impact on a number of mammalian physiological functions linked to obesity. The aim of this review is to present the evidence for a characteristic "obese-type" gut microbiota and to discuss studies linking microbial metabolic activities with mammalian regulation of lipid and glucose metabolism, thermogenesis, satiety, and chronic systemic inflammation. We focus in particular on short-chain fatty acids (SCFA) produced upon fiber fermentation in the colon. Although SCFA are reported to be elevated in the feces of obese individuals, they are also, in contradiction, identified as key metabolic regulators of the physiological checks and controls mammals rely upon to regulate energy metabolism. Most studies suggest that the gut microbiota differs in composition between lean and obese individuals and that diet, especially the high-fat low-fiber Western-style diet, dramatically impacts on the gut microbiota. There is currently no consensus as to whether the gut microbiota plays a causative role in obesity or is modulated in response to the obese state itself or the diet in obesity. Further studies, especially on the regulatory role of SCFA in human energy homeostasis, are needed to clarify the physiological consequences of an "obese-style" microbiota and any putative dietary modulation of associated disease risk.
肥胖现在被认为是一个全球性的主要公共卫生关注点,因为它易导致许多慢性人类疾病。自 20 世纪 80 年代以来,大多数发达国家的肥胖率急剧上升,肥胖显然伴随着全球范围内“西方”饮食和低能量消耗生活方式的采用。最近的研究报告表明,肥胖受试者的肠道微生物群落异常,肠道微生物代谢活动,特别是碳水化合物发酵和胆汁酸代谢,可以影响与肥胖相关的许多哺乳动物生理功能。本综述的目的是提出特征性“肥胖型”肠道微生物群落的证据,并讨论将微生物代谢活性与哺乳动物对脂质和葡萄糖代谢、产热、饱腹感和慢性全身炎症的调节联系起来的研究。我们特别关注纤维在结肠发酵产生的短链脂肪酸 (SCFA)。尽管据报道肥胖个体粪便中的 SCFA 升高,但它们也被认为是哺乳动物调节能量代谢所依赖的生理检查和控制的关键代谢调节剂。大多数研究表明,瘦人和肥胖个体的肠道微生物群落组成不同,饮食,特别是高脂肪低纤维的西方饮食,对肠道微生物群落有显著影响。目前尚不清楚肠道微生物群是否在肥胖中起因果作用,还是对肥胖状态本身或肥胖中的饮食进行调节。需要进一步的研究,特别是关于 SCFA 在人类能量平衡中的调节作用,以阐明“肥胖型”微生物群的生理后果以及任何可能的饮食对相关疾病风险的调节。